首页> 外文期刊>clinical nuclear medicine >Tchyphen;99m MIBI Uptake in Pulmonary SarcoidosisPreliminary Clinical Results and Comparison With Gahyphen;67
【24h】

Tchyphen;99m MIBI Uptake in Pulmonary SarcoidosisPreliminary Clinical Results and Comparison With Gahyphen;67

机译:Tchyphen;99m MIBI Uptake in Pulmonary SarcoidosisPreliminary Clinical Results and Comparison With Gahyphen;67

获取原文
           

摘要

NA;During tumor imaging research, the authors incidentally discovered that Tchyphen;99m MIBI is taken up by pulmonary sarcoidosis. In order to evaluate this uptake, they performed Tchyphen;99m MIBI planar and SPECT imaging in 7 patients and compared it with Gahyphen;67. Six out of 7 patients showed evident uptake of Tchyphen;99m MIBI in enlarged hilar lymph nodes. One of the patients, who had been on corticosteroid treatment, showed only faint uptake lpar;negative resultrpar;, in whom Gahyphen;67 uptake was seen in hilar lymph nodes although it was less evident than the uptake in the other patients. The lymph nodes were better demonstrated with Tchyphen;99m MIBI. The fact that enlarged hilar lymph nodes in a patient on corticosteroid treatment showed faint uptake suggests that Tchyphen;99m MIBI could be helpful for assessing the response to treatment. The preliminary experience in a limited number of patients showed that Tchyphen;99m MIBI is taken up by pulmonary sarcoidosis and it appears to be a potential alternative to Gahyphen;67. Further study is necessary to evaluate its ultimate role in pulmonary sarcoidosis imaging.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号